Teva's CFO Eyal Desheh said at the Oppenheimer annual conference in Tel Aviv, that the healthcare reform will reduce Teva's revenue by $80-100M a year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.